Kymera Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Kymera Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 68% to $78,592,000. The net income raised on -$146,962,000 and profit margin reached -187%. Total operating expenses were $244,122,000.
Profit Margin
| 2018 | 0 | -21.46M | |
|---|---|---|---|
| 2019 | 2.93M | -41.29M | -1407.36% |
| 2020 | 34.03M | -43.94M | -129.12% |
| 2021 | 72.83M | -97.99M | -134.55% |
| 2022 | 46.82M | -151.83M | -324.25% |
| 2023 | 78.59M | -146.96M | -186.99% |
KYMR Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 78.59M | 46.82M | 72.83M | 34.03M | 2.93M | 0 |
Cost of revenue | 189.08M | 2.97M | 2.39M | 62.10M | 825K | 0 |
Gross profit | -110.48M | 43.84M | 70.43M | -28.07M | 2.10M | 0 |
Operating exp. | ||||||
Research and development | 189.08M | 164.24M | 137.01M | 62.10M | 37.15M | 17.67M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 244.12M | 208.08M | 173.36M | 80.33M | 45.13M | 21.45M |
Operating income | -165.53M | -161.25M | -100.53M | -46.30M | -42.20M | -21.45M |
Other income (expenses), net | 18.56M | 6.44M | 313K | 711K | 959K | -16K |
Income before tax | -146.96M | -154.80M | -100.21M | -45.59M | -41.24M | -21.46M |
Income tax expense | 0 | -2.97M | -2.22M | -1.64M | 46K | 0 |
Net income | -146.96M | -151.83M | -97.99M | -43.94M | -41.29M | -21.46M |
Earnings per share | ||||||
Basic EPS | -2.52 | -2.82 | -2.04 | -2.53 | -0.93 | -1.07 |
Diluted EPS | -2.52 | -2.82 | -2.04 | -2.53 | -0.93 | -1.07 |
| Data source | Data source | Data source | Data source |